|
US8030343B2
(en)
*
|
2000-06-08 |
2011-10-04 |
Celgene Corporation |
Pharmaceutically active isoindoline derivatives
|
|
US7311905B2
(en)
*
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
|
EP2305795B1
(en)
|
2000-12-06 |
2019-07-03 |
Celularity, Inc. |
Method of collecting placental stem cells
|
|
ES2432493T3
(es)
|
2001-02-14 |
2013-12-03 |
Anthrogenesis Corporation |
Placenta de mamífero post-parto, su uso y células madre de la misma
|
|
US7498171B2
(en)
*
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
|
JP2006510606A
(ja)
|
2002-10-15 |
2006-03-30 |
セルジーン・コーポレーション |
骨髄異形成症候群を治療および管理するための選択的サイトカイン阻害剤の使用方法およびそれを含む組成物
|
|
AU2003298775B2
(en)
*
|
2002-11-26 |
2008-07-17 |
Anthrogenesis Corporation |
Cytotherapeutics, cytotherapeutic units and methods for treatments using them
|
|
US20050143344A1
(en)
*
|
2003-12-30 |
2005-06-30 |
Zeldis Jerome B. |
Methods and compositions using immunomodulatory compounds for the treatment and management of central nervous system disorders or diseases
|
|
WO2005097190A2
(en)
*
|
2004-03-26 |
2005-10-20 |
Celgene Corporation |
Systems and methods for providing a stem cell bank
|
|
EP1744748A4
(en)
*
|
2004-04-14 |
2009-08-12 |
Celgene Corp |
METHOD FOR USE OF SELECTIVE CYTOKINE-INHIBITORY MEDICAMENTS AND COMPOSITIONS CONTAINING THEREOF FOR THE TREATMENT AND SUPPLY OF MYELODYSPLASTIC SYNDROMES
|
|
US7244759B2
(en)
*
|
2004-07-28 |
2007-07-17 |
Celgene Corporation |
Isoindoline compounds and methods of making and using the same
|
|
CA2590903A1
(en)
*
|
2004-12-13 |
2006-06-22 |
Celgene Corporation |
Compositions comprising pde4 modulators and their use for the treatment or prevention of airway inflammation
|
|
WO2007005807A2
(en)
*
|
2005-06-30 |
2007-01-11 |
Anthrogenesis Corporation |
Repair of tympanic membrane using placenta derived collagen biofabric
|
|
HRP20130102T1
(hr)
*
|
2005-06-30 |
2013-03-31 |
Celgene Corporation |
Postupak dobivanja spojeva 4-amino-2-(2,6-dioksopiperidin-3-il)izoindolin-1,3-diona
|
|
US7928280B2
(en)
*
|
2005-07-13 |
2011-04-19 |
Anthrogenesis Corporation |
Treatment of leg ulcers using placenta derived collagen biofabric
|
|
EP1919365A2
(en)
*
|
2005-07-13 |
2008-05-14 |
Anthrogenesis Corporation |
Ocular plug formed from placenta derived collagen biofabric
|
|
US20070066512A1
(en)
*
|
2005-09-12 |
2007-03-22 |
Dominique Verhelle |
Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
|
|
US7878970B2
(en)
|
2005-09-28 |
2011-02-01 |
Boston Scientific Scimed, Inc. |
Apparatus and method for suspending a uterus
|
|
ZA200803929B
(en)
*
|
2005-10-13 |
2009-08-26 |
Anthrogenesis Corp |
Production of oligodendrocytes from placenta-derived stem cells
|
|
NZ597304A
(en)
|
2005-10-13 |
2013-06-28 |
Anthrogenesis Corp |
Immunomodulation using placental stem cells
|
|
ZA200804717B
(en)
*
|
2005-12-29 |
2010-02-24 |
Anthrogenesis Corp |
Improved composition for collecting and preserving a placental stem cells and methods of using the composition
|
|
PL2471907T3
(pl)
|
2005-12-29 |
2019-07-31 |
Celularity, Inc. |
Populacje komórek macierzystych łożyska
|
|
EP1976978A2
(en)
*
|
2005-12-29 |
2008-10-08 |
Anthrogenesis Corporation |
Co-culture of placental stem cells and stem cells from a second source
|
|
US9144483B2
(en)
|
2006-01-13 |
2015-09-29 |
Boston Scientific Scimed, Inc. |
Placing fixation devices
|
|
EP2617385B1
(en)
|
2006-03-16 |
2017-07-19 |
Boston Scientific Limited |
System for treating tissue wall prolapse
|
|
WO2007136640A2
(en)
*
|
2006-05-16 |
2007-11-29 |
Celgene Corporation |
Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
|
|
TW200806625A
(en)
*
|
2006-05-26 |
2008-02-01 |
Astrazeneca Ab |
Therapeutic compounds
|
|
US7993918B2
(en)
|
2006-08-04 |
2011-08-09 |
Anthrogenesis Corporation |
Tumor suppression using placental stem cells
|
|
WO2008021391A1
(en)
*
|
2006-08-15 |
2008-02-21 |
Anthrogenesis Corporation |
Umbilical cord biomaterial for medical use
|
|
WO2008042441A1
(en)
*
|
2006-10-03 |
2008-04-10 |
Anthrogenesis Corporation |
Use of umbilical cord biomaterial for ocular surgery
|
|
WO2008060377A2
(en)
|
2006-10-04 |
2008-05-22 |
Anthrogenesis Corporation |
Placental or umbilical cord tissue compositions
|
|
CN101622007A
(zh)
|
2006-10-06 |
2010-01-06 |
人类起源公司 |
天然(端肽)胎盘胶原组合物
|
|
US8562972B2
(en)
|
2006-10-23 |
2013-10-22 |
Anthrogenesis Corporation |
Methods and compositions for treatment of bone defects with placental cell populations
|
|
CA2677679A1
(en)
|
2007-02-12 |
2008-08-21 |
Anthrogenesis Corporation |
Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
|
|
NZ612888A
(en)
|
2007-02-12 |
2015-02-27 |
Anthrogenesis Corp |
Treatment of inflammatory diseases using placental stem cells
|
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
|
RU2536242C2
(ru)
|
2007-09-28 |
2014-12-20 |
Антродженезис Корпорейшн |
Угнетение опухолей с помощью плацентарного перфузата человека и выделенных из плаценты человека вспомогательных натуральных клеток-киллеров
|
|
WO2009073146A2
(en)
*
|
2007-11-29 |
2009-06-11 |
Celgene Corporation |
Use of immunomodulatory compounds for the treatment of transverse myelitis, multiple sclerosis, and other disorders
|
|
EP2235213A2
(en)
|
2007-12-20 |
2010-10-06 |
Celgene Corporation |
Use of micro-rna as a biomarker of immunomodulatory drug activity
|
|
US9078728B2
(en)
|
2007-12-28 |
2015-07-14 |
Boston Scientific Scimed, Inc. |
Devices and methods for delivering female pelvic floor implants
|
|
US8430807B2
(en)
|
2007-12-28 |
2013-04-30 |
Boston Scientific Scimed, Inc. |
Devices and methods for treating pelvic floor dysfunctions
|
|
US20090232796A1
(en)
*
|
2008-02-20 |
2009-09-17 |
Corral Laura G |
Method of treating cancer by administering an immunomodulatory compound in combination with a cd40 antibody or cd40 ligand
|
|
KR20200011604A
(ko)
|
2008-08-20 |
2020-02-03 |
안트로제네시스 코포레이션 |
개선된 세포 조성물 및 그의 제조 방법
|
|
CA2734446C
(en)
|
2008-08-22 |
2017-06-20 |
Anthrogenesis Corporation |
Methods and compositions for treatment of bone defects with placental cell populations
|
|
RU2015130665A
(ru)
|
2008-11-19 |
2018-12-24 |
Антродженезис Корпорейшн |
Амниотические адгезивные клетки
|
|
PE20120580A1
(es)
|
2009-02-10 |
2012-05-23 |
Celgene Corp |
Metodos para utilizar y composiciones que comprenden moduladores pde4 para tratamiento, prevencion y control de tuberculosis
|
|
NZ595440A
(en)
|
2009-03-25 |
2014-05-30 |
Anthrogenesis Corp |
Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
|
|
US9125716B2
(en)
|
2009-04-17 |
2015-09-08 |
Boston Scientific Scimed, Inc. |
Delivery sleeve for pelvic floor implants
|
|
EP2436387B1
(en)
|
2009-05-25 |
2018-07-25 |
Celgene Corporation |
Pharmaceutical composition comprising crbn for use in treating a disease of the cerebral cortex
|
|
EP3090999A1
(en)
*
|
2009-06-18 |
2016-11-09 |
Concert Pharmaceuticals Inc. |
Deuterated isoindoline-1, 3-dione derivatives as pde4 and tnf-alpha inhibitors
|
|
AU2013263763B2
(en)
*
|
2009-06-18 |
2016-05-19 |
Concert Pharmaceuticals, Inc. |
Deuterated isoindoline-1,3-dione derivatives as PDE4 and TNF-alpha inhibitors
|
|
MX353489B
(es)
|
2009-07-02 |
2018-01-16 |
Anthrogenesis Corp |
Metodo para producir eritrocitos sin celulas alimentadoras.
|
|
JP5753177B2
(ja)
*
|
2009-10-09 |
2015-07-22 |
セルジーン コーポレイション |
２−（１−フェニルエチル）イソインドリン−１−オン化合物を調製する方法
|
|
MX337566B
(es)
|
2010-01-05 |
2016-03-10 |
Celgene Corp |
Combinación de un compuesto inmunomodulador y una artemisinina o un derivado de ésta para tratar cáncer.
|
|
DK3284818T3
(da)
|
2010-01-26 |
2022-06-20 |
Celularity Inc |
Behandling af knoglerelateret kræft ved hjælp af placenta stamceller
|
|
EP2536706B1
(en)
|
2010-02-11 |
2017-06-14 |
Celgene Corporation |
Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
|
|
DK2556145T3
(en)
|
2010-04-07 |
2016-11-07 |
Anthrogenesis Corp |
Angiogenesis using placental stem cells
|
|
EP2555783A1
(en)
|
2010-04-08 |
2013-02-13 |
Anthrogenesis Corporation |
Treatment of sarcoidosis using placental stem cells
|
|
US20110318741A1
(en)
|
2010-06-15 |
2011-12-29 |
Schafer Peter H |
Biomarkers for the treatment of psoriasis
|
|
MX342995B
(es)
|
2010-07-13 |
2016-10-21 |
Anthrogenesis Corp |
Métodos de generar células asesinas naturales.
|
|
US8911348B2
(en)
|
2010-09-02 |
2014-12-16 |
Boston Scientific Scimed, Inc. |
Pelvic implants and methods of implanting the same
|
|
CN106008313B
(zh)
*
|
2010-12-22 |
2018-11-13 |
康塞特医药品有限公司 |
取代的异吲哚啉-1,3二酮衍生物
|
|
WO2012092485A1
(en)
|
2010-12-31 |
2012-07-05 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory rna molecules
|
|
MX347928B
(es)
|
2011-01-10 |
2017-05-19 |
Celgene Corp |
Derivados de fenetilsulfona isoindolina y su uso.
|
|
US9045417B2
(en)
|
2011-01-14 |
2015-06-02 |
Celgene Corporation |
Isotopologues of isoindole derivatives
|
|
WO2012145309A1
(en)
|
2011-04-18 |
2012-10-26 |
Celgene Corporation |
Biomarkers for the treatment of multiple myeloma
|
|
CA2834535A1
(en)
|
2011-04-29 |
2012-11-01 |
Celgene Corporation |
Methods for the treatment of cancer and inflammatory diseases using cereblon as a predictor
|
|
ES2707579T3
(es)
|
2011-06-01 |
2019-04-04 |
Celularity Inc |
Tratamiento del dolor usando citoblastos placentarios
|
|
US9938269B2
(en)
|
2011-06-30 |
2018-04-10 |
Abbvie Inc. |
Inhibitor compounds of phosphodiesterase type 10A
|
|
US9168120B2
(en)
|
2011-09-09 |
2015-10-27 |
Boston Scientific Scimed, Inc. |
Medical device and methods of delivering the medical device
|
|
WO2013055476A1
(en)
|
2011-09-09 |
2013-04-18 |
Anthrogenesis Corporation |
Treatment of amyotrophic lateral sclerosis using placental stem cells
|
|
ES2872967T3
(es)
|
2012-06-29 |
2021-11-03 |
Celgene Corp |
Métodos para determinar la eficacia de fármacos usando IKZF3 (AIOLOS)
|
|
US9587281B2
(en)
|
2012-08-14 |
2017-03-07 |
Celgene Corporation |
Cereblon isoforms and their use as biomarkers for therapeutic treatment
|
|
JP5934658B2
(ja)
*
|
2013-01-29 |
2016-06-15 |
Ｊｘエネルギー株式会社 |
イミド−ウレア化合物及びその製造方法、グリース用増ちょう剤並びにグリース組成物
|
|
AU2014215458A1
(en)
|
2013-02-05 |
2015-08-13 |
Anthrogenesis Corporation |
Natural killer cells from placenta
|
|
US9814555B2
(en)
|
2013-03-12 |
2017-11-14 |
Boston Scientific Scimed, Inc. |
Medical device for pelvic floor repair and method of delivering the medical device
|
|
CN105358177B
(zh)
|
2013-04-17 |
2018-11-23 |
西格诺药品有限公司 |
包含tor激酶抑制剂和imid化合物的联合疗法用于治疗癌症
|
|
US9962251B2
(en)
|
2013-10-17 |
2018-05-08 |
Boston Scientific Scimed, Inc. |
Devices and methods for delivering implants
|
|
US20170087129A1
(en)
|
2014-05-16 |
2017-03-30 |
Celgene Corporation |
Compositions and methods for the treatment of atherosclerotic cardiovascular diseases with pde4 modulators
|
|
WO2015200795A1
(en)
|
2014-06-27 |
2015-12-30 |
Celgene Corporation |
Compositions and methods for inducing conformational changes in cereblon other e3 ubiquitin ligases
|
|
WO2017070291A1
(en)
|
2015-10-21 |
2017-04-27 |
Celgene Corporation |
Pde4 modulators for treating and preventing immune reconstitution inflammatory syndrome (iris)
|
|
WO2017117118A1
(en)
|
2015-12-28 |
2017-07-06 |
Celgene Corporation |
Compositions and methods for inducing conformational changes in cereblon and other e3 ubiquitin ligases
|
|
AU2017368332A1
(en)
|
2016-12-03 |
2019-06-13 |
Juno Therapeutics, Inc. |
Methods for modulation of CAR-T cells
|
|
US20200078404A1
(en)
|
2017-05-01 |
2020-03-12 |
Juno Therapeutics, Inc. |
Combination of a cell therapy and an immunomodulatory compound
|
|
AU2018275894B2
(en)
|
2017-06-02 |
2025-04-24 |
Juno Therapeutics, Inc. |
Articles of manufacture and methods for treatment using adoptive cell therapy
|
|
EP3644721A1
(en)
|
2017-06-29 |
2020-05-06 |
Juno Therapeutics, Inc. |
Mouse model for assessing toxicities associated with immunotherapies
|
|
CA3077325A1
(en)
|
2017-09-28 |
2019-04-04 |
Celularity Inc. |
Tumor suppression using human placenta-derived intermediate natural killer (pink) cells in combination with an antibody
|
|
AU2018358067A1
(en)
|
2017-11-01 |
2020-05-07 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for B-cell maturation antigen
|
|
WO2019089858A2
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods of assessing or monitoring a response to a cell therapy
|
|
WO2019118937A1
(en)
|
2017-12-15 |
2019-06-20 |
Juno Therapeutics, Inc. |
Anti-cct5 binding molecules and methods of use thereof
|
|
AU2019211931B2
(en)
*
|
2018-01-29 |
2023-08-10 |
Medshine Discovery Inc. |
Crystal form of 1H-imidazo[4,5-b]pyridine-2(3H)-one compound and preparation process therefor
|
|
KR20200123155A
(ko)
|
2018-02-21 |
2020-10-28 |
셀진 코포레이션 |
Bcma-결합 항체 및 이의 용도
|
|
WO2020097403A1
(en)
|
2018-11-08 |
2020-05-14 |
Juno Therapeutics, Inc. |
Methods and combinations for treatment and t cell modulation
|
|
KR20210104713A
(ko)
|
2018-11-16 |
2021-08-25 |
주노 쎄러퓨티크스 인코퍼레이티드 |
Ｂ 세포 악성 종양 치료를 위한 조작된 ｔ 세포 투약 방법
|
|
PL3886875T3
(pl)
|
2018-11-30 |
2024-09-09 |
Juno Therapeutics, Inc. |
Metody leczenia z wykorzystaniem adoptywnej terapii komórkowej
|
|
CA3123303A1
(en)
|
2019-01-29 |
2020-08-06 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for receptor tyrosine kinase like orphan receptor 1 (ror1)
|
|
CN113527179B
(zh)
*
|
2020-04-13 |
2023-07-07 |
苏州璞正医药有限公司 |
链烃取代异吲哚啉-1,3-二酮类pde4抑制剂及其药物用途
|
|
CN113956190B
(zh)
*
|
2021-10-29 |
2023-05-02 |
大连理工大学 |
可激活肿瘤细胞焦亡的细胞器靶向光敏剂及其制备方法和应用
|
|
EP4543923A1
(en)
|
2022-06-22 |
2025-04-30 |
Juno Therapeutics, Inc. |
Treatment methods for second line therapy of cd19-targeted car t cells
|
|
WO2024097905A1
(en)
|
2022-11-02 |
2024-05-10 |
Celgene Corporation |
Methods of treatment with t cell therapy and immunomodulatory agent maintenance therapy
|